mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0004 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0006 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.0006 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0007 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |